Abstract
Background: Czech Republic is the first in the incidence of colorectal carcinoma (CRC) in all over the world. There is 60% development of liver metastases in the patients with colorectal carcinoma (LMCRC).
Liver resection as the most effective therapeutic choice potentially curative is available only in 20% of the patients with CRC. Surgery with adjuvant chemotherapy leads to 5yr. survival in 50% of patients with LMCRC.
Aim of study: To evaluate how many patients with LMCRC are indicated for liver surgery and how many patients are predicted for surgery every year in Czech Republic. Methods: A questionnaire was sent to 140 surgical department of Czech Republic in 2001, 142 in 2009 respectively with questions regarding to surgical treatment of LMCRC.
The data were compared to similar survey evaluation on The Netherlands and Austria and data from Czech national oncology registry. Results: 217 liver resection (57 major including) resp. 466 (140 major including) were done in Czech Republic in 2000, resp. 2008 (114.7% growth).
Number of liver resections providing in 2000 resp. 2008 compared to predictive number of liver surgery was 24.1%, resp. 49.4% (approx. 100% growth). Number of liver resections for primary as well for secondary malignancy in Czech national oncology registry was involved together.
Conclusion: High incidence of CRC leads to high incidence of LMCRC in Czech Republic. About 1.000 patients with LMCRC can be expected in Czech Republic in the 60% development of LMCRC and 20% resectability every year.
Only 50% of patients with LMCRC have the chance for adequate therapy nowadays. For the evaluation of quality of surgical department other studies are needed.